Impact of Certain Allopathic Medicines on Inhibitory Activity of Mezereum 200 against Candidaalbicans: An In-vitrostudy

Impact of Certain Allopathic Medicines on Inhibitory Activity of Mezereum 200 against Candidaalbicans: An In-vitrostudy

Girish Gupta1, A. K. Srivastava2, Naveen Gupta3, Gaurang Gupta4, Sunil Mishra5

1Chief Consultant

2Medical Mycologist

3Senior Consultant (Research and Publication)

4Physician (Academics)

5Lab. Technician

Address for correspondence

Dr. Girish Gupta

Gaurang Clinic and Centre for Homoeopathic Research

B-1/41, Sector A, Opp. Novelty (Aliganj), Kapoorthala, Aliganj, Lucknow-226 024 (U.P.), INDIA

Phone: 0522-4004370, 2326464,

E-mail: girishguptadr@gmail.com,

Website: http://www.gcchr.com

Abstract

The use of allopathic medicines simultaneously with homoeopathic treatment had been condemned by Homoeopathic physicians since the inception of Homoeopathy on the basis of their prejudice thathomoeopathic medicineswould be neutralized/antidoted by allopathic medicines.

The aim of this in-vitro study was to provide experimental proof, to validate or dismiss the belief of contemporary homoeopathic physicians of restricting simultaneous use of allopathic medicines along with homoeopathic medicines.

The result of these experiments have shown that there is no negative impact of these allopathic medicines on the inhibition in growth of human pathogenic fungus Candidaalbicans by Mezereum 200 in in-vitro condition.

This experiment is only an effort to elicit the effect of above mentioned items on the inhibition in growth of human pathogenic fungus Candidaalbicans by Mezereum 200 in in-vitro condition and has nothing to do with any known or unknown side effects / contraindications of the allopathic medicines.

PDF